Stanford Psychedelics: Boris Heifets

Business Trip by PsyMed Ventures, a podcast about the business of psychedelics

Welcome back to Business Trip by PsyMed Ventures, a podcast about the business of psychedelics! 🍄

Stanford University is one of the leading universities in psychedelic science, focusing on understanding how psychedelics work in the body. 

This is part 2 of a 3-part series, where we will explore groundbreaking discoveries via leading Stanford researchers who are revealing the significance of psychedelic science in modern research. We continue with Boris Heifets.

Boris Heifets, an assistant professor at Stanford's School of Medicine. Boris leads the Heifets Lab, which is dedicated to understanding and improving on powerful, rapid-acting therapies for psychiatric disease, such as ketamine, MDMA and psilocybin. Boris is an anesthesiologist and neurologist, a combination that uniquely positions him to design a research study evaluating the effect of ketamine on patients under anesthesia with depression.

In this episode we discuss:

• Ketamine’s antidepressant effects under anesthesia

• How setting impacts psilocybin in mice

• The key components of psychedelic therapy to demonstrate efficacy

• Anesthesiology principles to ensure safety in psychedelic research

Listen to the episode here, on Spotify, or on Apple Podcasts.

Once you've finished the episode, we'd love to hear your thoughts! Tweet us at @psymedventures to share your views.

P.S. Do you know someone who would enjoy the Business Trip by PsyMed Ventures podcast? Feel free to share this newsletter by clicking the link below and hitting the ❤️ button on this post to help us reach more people on Substack 🙏